L-DOPA (L-dihydroxyphenylalanine) (BSA)

Applications: \nSuitable for use in ELISA, Immunohistochemistry, Immunocytochemistry. Other applications not tested.\n\nRecommended Dilution:\nOptimal dilutions to be determined by the researcher.\n\nStorage and Stability:\nLyophilized powder may be stored at -20 degrees C. Stable for 12 months at -20 degrees C. Reconstitute with sterile ddH2O and 0.1% merthiolate. Aliquot to avoid repeated freezing and thawing. Store at -20 degrees C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.

Prices direct from United States Biological

Quick response times

Exclusive Biosave savings/discounts

SPECIFICATIONS

Catalog Number

L1590-01A

Size

1mg

Applications

ELISA, ICC, IHC

Form

Supplied as a lyophilized powder.

Purity

Purified

References

o MONS N., DANEL N and GEFFARD M. Visualization of L-dihydroxyphenylalanine in rat brain by using specific antibodies. Brain Res., (1988), 451, 403-407.\no OKAMURA H., KITAHAMA K., MONS. N., IBATA Y., JOUVET M. and GEFFARD M. L-DOPA-immunoreactive neurons in the rat hypothalamic tuberal region. Neurosci. Letters, (1988), 95, 42-46.\no KITAHAMA K., MONS N., OKAMURA M., JOUVET M. and GEFFARD M. Endogenous L-DOPA, its immunoreactivity in neurons of midbrain and its projection fields in the cat. Neurosci. Letters, (1988), 95, 47-52.\no MONS N., TISON F. and GEFFARD M. Identification of L-DOPA-dopamine and L-DOPA cell bodies in the rat mesencephalic dopaminergic cell systems. Synapse, (1989), 4, 99-105. \no TISON F., MONS N., ROUET-KARAMA S., GEFFARD M. and HENRY P. Endogenous L-DOPA in the rat dorsal vagal complex : an immunocytochemical study by light and election microscopy. Brain Res., (1989), 497, 260-270.\no MONS N., TISON F. and GEFFARD M. Existence of L-DOPA immunoreactive neurons in the rat preoptic area and anterior hypothalamus. Neuroendocrinology, (1990) 51, 425-428.\no TISON F., MONS N. , GEFFARD M. and HENRY P. Immunohistochemistry of endogenous L-DOPA in the rat posterior hypothalamus. Histochemistry, (1990) 93, 655-660.\no MANIER M., FEUERSTEIN C., PASSAGIA J.G., MOUCHET P., MONS N., GEFFARD M. and THIBAULT J. Evidence for the existence of L-DOPA-and dopamine-immunoreactive nerve cell bodies in the candal part of the dorsal motor nucleus of the ragus nerve. J. Chem. Neuroanat., (1990) 3, 193-206.\no OKAMURA H., KITAHAMA K., MONS N., MATSUMOTO Y., IBATA Y. and GEFFARD M. Heterogeneous distribution of L-DOPA immunoreactivity in dopaminergic neurons of the rat midbrain. In \"Basic, clinical, an therapeutic aspects of Alzheimer's and Parkinson's diseases\" (Eds. NAGATSU T., FISHER A. and YOSHIDA M.) Plenum Press, New-York and London, (1991), 423-426.\no TISON F., MONS N., GEFFARD M. and HENRY P. Decarboxylation of exogenous L-DOPA to dopamine in non-catecholaminergic neurons of the brain. An immunohistochemical study in the rat. J. of Neural Transmission, (1991) 3, 27-39.\no LAGIER B., CHARRIER M.C., GEFFARD M. and DOUTREMEPUICH C. Effects of polyclonal antibodies against conjugated L-DOPA or against conjugated acetylcholine on experimental venous thrombosis. Thrombosis Res., (1992) 65, 275-280.\no ARAI R., KARASAWA N., GEFFARD M., CALAS A., NAGATSU T. and NAGATSU I. Immunohistochemical evidence that central serotonin neurons produce dopamine from exogenous L-DOPA in the rat, with reference to the involvement of aromatiL- amino acid decarboxylase. Brain Res., (1994) 667, 295-299.\no ARAI R., KARASAWA N., GEFFARD M. and NAGATSU I. L-DOPA is converted to dopamine in serotonergic fibers of the stratium of the rat : a double-labeling immunofluorescence study. Neurosc. Letters, (1995) 195, 195-198.\no YUE J.-L., OKAMURA H., GOSHIMA Y., NAKAMURA S., GEFFARD M. and MISU Y. Baroreceptor-aortic nerve-mediated release of endogenous L-3,4-dihydroxyphenylalanine and its tonic depressor function in the nucleus tractus solitarii of rats. Neuroscience, (1995) 62, 145-161.\n